Relay Therapeutics Strengthens Computational Leadership Team with Addition of Patrick Riley, Ph.D. Dr. Riley brings extensive experience in artificial intelligence with a focus on drug discovery May 10, 2021 06:00 ET | Source: Relay Therapeutics, Inc. Relay Therapeutics, Inc. Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading edge computational and experimental technologies, today announced the appointment of Patrick Riley, Ph.D., as senior vice president of artificial intelligence. Dr. Riley is an industry expert in artificial intelligence and machine learning, bringing 15 years of experience from Google and extensive knowledge in applying these technologies to drug discovery. Dr. Riley will lead a computational team and report to group head, Pat Walters.